Inflammatory Bowel Disease (IBD) affects millions of people, often leaving them caught between painful symptoms and treatments that do not always last. In this episode of Biome Breakthroughs, Shaina and Jason break down why Fecal Microbiota Transplantation (FMT) is becoming one of the most promising options for IBD, and specifically ulcerative colitis.

You will hear how FMT restores balance in the gut microbiome, why donor quality can change outcomes, and how new approaches like capsules and longer treatment protocols are improving remission rates. With real patient stories and medical insights, this conversation explores how IBD care is evolving beyond steroids and biologics.

Inflammatory Bowel Disease is not simple, but there is hope. For patients and professionals alike, this episode opens the door to a future where FMT may soon be a standard part of treatment.

Ready to take gut health further? Subscribe now and hit the bell to stay updated on the latest breakthroughs in microbiome science and FMT.

Join the conversation: Drop your questions or share your experiences with Inflammatory Bowel Disease (IBD) and microbiome-based treatments in the comments. Your insights help shape our future episodes.

Explore more resources:

• Learn about our clinical work: https://novelbiome.com
• Read our latest blogs: https://novelbiome.com/blog
• Connect with us on LinkedIn: https://www.linkedin.com/company/novelbiome

#InflammatoryBowelDisease #IBD #UlcerativeColitis #CrohnsDisease #GutHealth #FecalMicrobiotaTransplant #FMT #MicrobiomeResearch #ChronicIllnessSupport #HopeForIBD #FutureOfMedicine #ClinicalInsights